Showing results (251-260 of 277) with videos related to

Sort By:
Pageof 28
Biomarker Research|January 3, 2025
A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphomaJie Zha, Qinwei Chen, Wei Zhang, et al.
The Journal of Infection|October 28, 2023
Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical trial in healthy Chinese adultsZhili Jin, Jingxuan Wu, Ying Wang, et al.
Cancer Research Communications|October 24, 2025
A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic MalignanciesDejan Juric, Daniel Anderson, Afshin Dowlati, et al.
Frontiers in Oncology|July 25, 2022
Penpulimab for Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter, Single-Arm, Pivotal Phase I/II Trial (AK105-201)Yuqin Song, Keshu Zhou, Chuan Jin, et al.
Cancer Science|October 11, 2018
Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failureShaoxuan Hu, Yuqin Song, Xiuhua Sun, et al.
Cell Metabolism|October 16, 2024
Lighting up arginine metabolism reveals its functional diversity in physiology and pathologyRui Li, Yan Li, Kun Jiang, et al.
Haematologica|January 18, 2024
Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumorsYuqin Song, Junning Cao, Qingyuan Zhang, et al.
Communications Medicine|April 21, 2026
Chidamide synergizes with cisplatin-etoposide to trigger pyroptosis and anti-tumor immunity in diffuse large B-cell lymphomaJianbo Wu, Yingying Ye, Danyang Ran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2023
The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical TrialTingyu Wang, Xiuhua Sun, Lihua Qiu, et al.
Blood Advances|November 1, 2021
Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignanciesConstantine S Tam, Meletios Dimopoulos, Ramon Garcia-Sanz, et al.
Pageof 28